A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Clinical trial NCT05344469 · RECRUITING
Trial details
- NCT number
- NCT05344469
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-10
- Primary completion
- 2029-05-30
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.